The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Recommendations for the management of postmenopausal vaginal atrophy
Abstract
Unlike hot flushes and night sweats which resolve spontaneously in time, atrophic symptoms affecting the vagina and lower urinary tract are often progressive and frequently require treatment. The prevalence of vaginal dryness increases as a woman advances through the postmenopausal years, causing itching, burning and dyspareunia, and sexual activity is often compromised. But, despite the various safe and effective options, only a minority (about 25% in the Western world and probably considerably less in other areas) will seek medical help. Some of this reluctance is due to the adverse publicity for hormone replacement therapy (HRT) over recent years that has suggested an increased risk of breast cancer, heart disease and stroke. But, regardless of whether these scares are justified, local treatment of vaginal atrophy is not associated with these possible risks of systemic HRT. Other reasons for the continued suffering in silence may be cultural and an understandable reluctance to discuss such matters, particularly with a male doctor, but the medical profession must also take much of the blame for failing to enquire of all postmenopausal women about the possibility of vaginal atrophic symptoms. Vaginal dryness can be helped by simple lubricants but the best and most logical treatment for urogenital atrophy is to use local estrogen. This is safe, effective and with few contraindications. It is hoped that these guidelines and recommendations, produced to coincide with World Menopause Day 2010, will help to highlight this major cause of distress and reduced quality of life and will encourage women and their medical advisers all over the world to seek and provide help.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CARDOZO, L. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00175-6 · Cited by 388
Are changes in sexual functioning during midlife due to aging or menopause?
Dennerstein, L., Dudley, E., & Burger, H. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01978-1 · Cited by 343
Barnabei, V. M., Cochrane, B. B., Aragaki, A. K., Nygaard, I., Williams, R. S., McGovern, P. G., Young, R. L., Wells, E. C., OʼSullivan, M. J., Chen, B., et al. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000158120.47542.18 · Cited by 320
Bygdeman, M., & Swahn, M. L. (1996) · Maturitas · doi:10.1016/0378-5122(95)00955-8 · Cited by 299
Diagnosis and treatment of atrophic vaginitis.
Bachmann, G. A., & Nevadunsky, N. S. (2000) · PubMed · Cited by 298
Menopause and sexuality: Prevalence of symptoms and impact on quality of life
Nappi, R. E., & Lachowsky, M. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.03.021 · Cited by 296
Management of post-menopausal vaginal atrophy and atrophic vaginitis
Castelo-Branco, C., Cancelo, M. J., Villero, J., Nohales, F., & Juliá, M. D. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.06.014 · Cited by 281
Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones
Leiblum, S. R. (1983) · JAMA · doi:10.1001/jama.249.16.2195 · Cited by 263
Utian, W. H., Archer, D. F., Bachmann, G. A., Gallagher, J. C., Grodstein, F., Heiman, J. R., Henderson, V. W., Hodis, H. N., Karaś, R., Lobo, R. A., et al. (2007) · Cited by 232
Age-related pelvic floor modifications and prolapse risk factors in postmenopausal women
Tinelli, A., Malvasi, A., Rahimi, S., Negro, R., Vergara, D., Martignago, R., Pellegrino, M., & Cavallotti, C. (2010) · Menopause · doi:10.1097/gme.0b013e3181b0c2ae · Cited by 215
Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative
Pastore, L. M., Carter, R. A., Hulka, B. S., & Wells, E. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.06.019 · Cited by 210
Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.-L., Girard, G., Baron, M., Ayotte, N., Moreau, M., et al. (2009) · Menopause · doi:10.1097/gme.0b013e31819e85c6 · Cited by 191
Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.-L., Girard, G., Baron, M., Ayotte, N., Moreau, M., et al. (2009) · Menopause · doi:10.1097/gme.0b013e31819e8e2d · Cited by 190
Vaginal pH as a marker for bacterial pathogens and menopausal status
Caillouette, J. C., Sharp, C. F., Zimmerman, G. J., & Roy, S. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70345-4 · Cited by 189
Graziottin, A., & Leiblum, S. R. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.00129.x · Cited by 182
IMS Updated Recommendations on postmenopausal hormone therapy
Issued on behalf of the Board of th, Pines, A., Sturdee, D. W., Birkhäuser, M. H., Schneider, H. P. G., Gambacciani, M., & Panay, N. (2007) · Climacteric · doi:10.1080/13697130701361657 · Cited by 171
Self-citationEndometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet
Weisberg, E., Ayton, R., Darling, G., Farrell, E., Murkies, A., O'Neill, S., Kirkegard, Y., & Fraser, I. (2005) · Climacteric · doi:10.1080/13697130500087016 · Cited by 159
Impact of menopause on collagen subtypes in the arcus tendineous fasciae pelvis
Moalli, P. A., Talarico, L. C., Sung, V. W., Klingensmith, W. L., Shand, S. H., Meyn, L. A., & Watkins, S. C. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.08.040 · Cited by 159
Shou-qin, L. (2008) · Zhongguo shiyong fuke yu chanke zazhi · Cited by 156
Blümel, J. E., Chedraui, P. A., Barón, G., Belzares, E., Bencosme, A., Calle, A., Espinoza, M. T., Flores, D., Izaguirre, H., León-León, P., et al. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181a4e317 · Cited by 145
Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy
Heinemann, C., & Reid, G. (2005) · Canadian Journal of Microbiology · doi:10.1139/w05-070 · Cited by 144
Efficacy and tolerability of local estrogen therapy for urogenital atrophy
Archer, D. F. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181a95581 · Cited by 142
Biglia, N., Peano, E., Sgandurra, P., Moggio, G., Panuccio, E., Migliardi, M., Ravarino, N., Ponzone, R., & Sismondi, P. (2010) · Gynecological Endocrinology · doi:10.3109/09513591003632258 · Cited by 142
Prevalence and Determinants of Vaginal Flora Alterations in Postmenopausal Women
Pabich, W. L., Fihn, S. D., Stamm, W. E., Scholes, D., Boyko, E. J., & Gupta, K. (2003) · The Journal of Infectious Diseases · doi:10.1086/378203 · Cited by 141
Urogenital ageing and its effect on sexual health in older British women
Barlow, D. H., Cardozo, L. D., Francis, R. M., Griffin, M., Hart, D. M., Stephens, E., & Sturdee, D. W. (1997) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb10655.x · Cited by 138
Self-citationEfficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally
Bachmann, G. A., Bouchard, C., Hoppe, D., Ranganath, R., Altomare, C. J., Vieweg, A. J., Graepel, J., & Helzner, E. C. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181a48c4e · Cited by 124
The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women
(2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31805170eb · Cited by 124
Phillips, C. H., Anthony, F. W., Benyon, C., & Monga, A. K. (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00773.x · Cited by 119
The Asian Menopause Survey: Knowledge, perceptions, hormone treatment and sexual function
Huang, K., Xu, L., Nasri, N., & Jaisamrarn, U. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.11.015 · Cited by 118
Women's perception of sexuality around the menopause: Outcomes of a European telephone survey
Nappi, R. E., & Nijland, E. A. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.10.036 · Cited by 115
Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview
Al-Baghdadi, O., & Ewies, A. A. A. (2009) · Climacteric · doi:10.1080/13697130802585576 · Cited by 109
van der Laak, J. A. W. M., de Bie, L. M. T., de Leeuw, H., de Wilde, P. C. M., & Hanselaar, A. G. J. M. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.6.446 · Cited by 109
Minimized estradiol absorption with ultra-low-dose 10 μg 17β-estradiol vaginal tablets
Eugster-Hausmann, M., Waitzinger, J., & Lehnick, D. (2010) · Climacteric · doi:10.3109/13697137.2010.483297 · Cited by 107
Genazzani, A. R., Schneider, H. P. G., Panay, N., & Nijland, E. A. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600842463 · Cited by 99
Self-citationRecognizing and Treating Urogenital Atrophy in Postmenopausal Women
Goldstein, I. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1384 · Cited by 98
Raghunandan, C., Agrawal, S., Dubey, P., Choudhury, M., & Jain, A. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01667.x · Cited by 90
Sexual expression and its determinants in the post-menopausal woman
Bachmann, G. A., Leiblum, S. R., Kemmann, E., Colburn, D., Swartzman, L. C., & Shelden, R. M. (1984) · Maturitas · doi:10.1016/0378-5122(84)90062-8 · Cited by 78
Calleja‐Agius, J., & Brincat, M. (2009) · Climacteric · doi:10.1080/13697130902814751 · Cited by 77
Sexual Oncology: Sexual Health Issues in Women with Cancer
Krychman, M., Pereira, L., Carter, J., & Amsterdam, A. (2006) · Oncology · doi:10.1159/000100521 · Cited by 74
Vaginal Hormone Therapy for Urogenital and Menopausal Symptoms
Ballagh, S. A. (2005) · Seminars in Reproductive Medicine · doi:10.1055/s-2005-869480 · Cited by 61
Haspels, A. A., Luisi, M., & Kicovic, P. M. (1981) · Maturitas · doi:10.1016/0378-5122(81)90041-4 · Cited by 56
The effects of postmenopausal Vitamin D treatment on vaginal atrophy
Yıldırım, B., Kaleli̇, B., Düzcan, E., & Topuz, O. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.02.008 · Cited by 56
Taylor, A. H., Guzail, M., & Al‐Azzawi, F. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08371.x · Cited by 55
Endometrial safety of ultra-low-dose Vagifem 10 μg in postmenopausal women with vaginal atrophy
Ulrich, L. S. G., Naessén, T., Elia, D., Goldstein, J. A., Eugster-Hausmann, M., & on behalf of the VAG-1748 trial investigators (2010) · Climacteric · doi:10.3109/13697137.2010.481058 · Cited by 49
Age of menopause in black women in South Africa
Walker, A. R. P., Walker, B. F., Ncongwane, J., & TSHABALALA, E. N. (1984) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1984.tb04853.x · Cited by 42
Prevalence and persistence of human papillomavirus in postmenopausal age women
Smith, E., Ritchie, J. M., Levy, B. T., Zhang, W., Wang, D., Haugen, T. H., & Turek, L. P. (2003) · Cancer Detection and Prevention · doi:10.1016/s0361-090x(03)00104-1 · Cited by 40
Urogenital effects of hormone therapy
Robinson, D., & Cardozo, L. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(02)00085-4 · Cited by 34
Abernethy, K. (1997) · Cited by 30
Melisko, M. E., Rugo, H. S., DeLuca, A. N., Park, J. J., Moasser, M. M., Münster, P. N., & Goldman, M. E. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-09-5038 · Cited by 10
Cited by
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Self-citationThe 2012 Hormone Therapy Position Statement of The North American Menopause Society
(2012) · Menopause · doi:10.1097/gme.0b013e31824b970a · Cited by 785
Portman, D. J., & Gass, M. L. S. (2014) · Menopause · doi:10.1097/gme.0000000000000329 · Cited by 688
Hormone-replacement therapy: current thinking
Lobo, R. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.164 · Cited by 484
Kingsberg, S. A., Wysocki, S., Magnus, L., & Krychman, M. L. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12190 · Cited by 481
Metadata
- Authors
- Sturdee, D. W., & Panay, N.
- Venue
- Climacteric
- Publisher
- Informa UK Limited
- Published
- 2010-09-30
- Volume
- 13
- Issue
- 6
- Pages
- 509-522
- ISSN
- 1369-7137 (ISSN-L)
- 1473-0804
- OpenAlex
- W2149935129
- Cited by
- 527
- References
- 50
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.